Researchers from SciLifeLab / Uppsala University, Sweden, and the Broad Institute, USA, have identified both similarities and differences between a single
tumour type in multiple dogs breeds; a finding they believe parallels the situation in the cancer of human patients.
An early sign that this might be the case came from a small clinical trial testing a new drug that has been developed without a particular
tumour type in mind.
Researchers from Uppsala University, Sweden, and the Broad Institute, USA, have identified both similarities and differences between a single
tumour type in multiple dogs breeds; a finding they believe parallels the situation in the cancer of human patients.
Not exact matches
A doctor exams mammograms, a special
type of X-ray of the breasts, which is used to detect
tumours as part of a regular cancer prevention medical check - up at a clinic
in Nice, south eastern France January 4, 2008.
Molecular characterization of the cells that undergo cell fate transition upon oncogenic Pik3ca expression demonstrated a profound oncogene - induced reprogramming of these newly formed cells and identified gene expression signatures, characteristic of the different cell fate switches, which was predictive of the cancer cell of origin,
tumour type and clinical outcomes
in women with breast cancers.
«However, many patients do not respond because myeloid derived suppressor cells (MDSCs), a
type of inhibitory cell, are present
in the
tumour microenvironment.»
The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of
tumours in 50 % of patients suffering from early HER - 2 - negative breast cancer, the most common
type of breast cancer.
In future, levels of a modified protein present in many types of tumour may help predict whether it is likely to sprea
In future, levels of a modified protein present
in many types of tumour may help predict whether it is likely to sprea
in many
types of
tumour may help predict whether it is likely to spread.
A COMPOUND that slows the proliferation of triple - negative breast cancer cells
in lab tests could lead to the first drugs to target this aggressive
type of
tumour.
Decitabine is approved by the U.S. Food and Drug Administration to treat myelodysplastic syndromes and leukemia, and for use
in clinical trials for several
types of solid -
tumour cancers including colorectal.
Tumours which carry mutations
in KRAS genes (40 % of CCR) or BRAF genes (between 5 and 15 % of these
types of cancers) are ineffectively treated and have poor prognosis.
Seen
in this light, a variety of
tumour types can originate from the same organ.
The researchers found five different sub-
types of HL among the patients studied: 247 cases of the nodular sclerosis (NS)
type,
in which the
tumour nodules are large; 105 of mixed cellularity, where a mixture of different
types of inflammatory cells are involved; 58 lymphocyte rich, the sub-
type with the best outcome; 68 «others»; and 143 «not otherwise specified» (NOS).
NGS was possible
in 117 (76.5 %) patients and revealed that 66 patients had «all RAS» wild -
type tumours with no mutations
in KRAS; NRAS; BRAF; or PIK3CA genes and 51 patients had
tumours harbouring a mutation
in at least one of these genes.
KRAS exon 2 mutations were found
in approximately 15 % of the
tumours that were originally identified as wild -
type.
The team used five
types of antibiotics — including one used to treat acne (doxycycline)-- on cell lines of eight different
types of
tumour and found that four of them eradicated the cancer stem cells
in every test.
«Some of these genes were either increased or decreased
in the area of the
tumour, no matter the
type of breast cancer, and this is important because within the patterns we identified were predictable alterations.
The research team with international collaborators analysed more than 100 patient samples from ovarian and other cancer
types to discover a distinct population of cells found
in some
tumours.
The same approach may be useful for boosting the effects of chemotherapy
in other
types of solid
tumour with high levels of stroma, Ganss says.
The CNIO researchers show that cell defects caused by the inhibition of Cdh1 are independent of the presence of the p53 molecule, which is mutated
in different
types of
tumours.
The team also found that there were also cases of other cancer
types in families with these hereditary mutations such as leukemias and brain
tumours.
While it is present on a number of different
types of cells
in the body, it is expressed at higher levels on metastatic
tumour cells, including those which have spread from the lung.
Although most of the work has been carried out using
in vivo studies, Asst Prof Gasser has been collaborating with Dr Joanne Ngeow at the National Cancer Centre Singapore to characterise the process
in different
types of human
tumours.
It is known that a diet rich
in fat can increase the risk of developing prostate cancer, and that obese people are more prone to develop this
type of
tumour.
They analysed about a million different cell mutations
in more than 7,000
tumours from the Cancer Genome Atlas covering 24
types of cancer.
IBM's Watson, the supercomputer that famously won the TV quiz Jeopardy!
in 2011, is analysing gene sequences from the most aggressive
types of brain
tumours.
The DNA of BKV has been discovered
in several
types of human cancers including prostate
tumours, and mouse studies suggest the virus can trigger cancer.
Intriguingly, previous research found that RASAL2 was lost
in some of the luminal
type of breast
tumours, where it acts as a
tumour suppressor.
In recent years, researchers have discovered several ways of using genome sequencing of
tumours to predict whether an individual cancer patient will benefit from a specific
type of medicine.
In future, other switches could be identified in other types of tumour cel
In future, other switches could be identified
in other types of tumour cel
in other
types of
tumour cell.
So they then went on to study the genomes of a
type of paediatric brain cancer characterised not only by a mutated polymerase — like
in the
tumours previously examined — but also by an inactivated repair system.
It recognises the four most common
types of cancer — prostate, lung, colon and breast cancer — at a very early stage, namely when the level of calcium
in the blood is elevated due to the developing
tumour.
In the genome of
tumour cells of 11 patients, the scientists observed the insertion of a viral DNA segment from adeno - associated virus
type 2, known as AAV2.
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weslon A, Modali R, Harris CC, Vogelstein B. Mutations
in the p53 gene occur
in diverse human
tumour types.
We see extensive variability
in genomes among
tumours of different tissue
types, among different patients within a tissue
type and among subclones within a given patient's cancer.
Perfusion of microvessels
in Tie2PEKO mice was further confirmed by similar extent of hypoxic areas as compared to
tumours growth
in wild -
type mice (Supplementary Fig. 12b).
Dr Steve Pollard and his team are developing potential new treatments for the most common
type of brain
tumour in adults, known as glioblastoma multiforme.
Breast and ovarian
tumours lacking one of these two genes are more sensitive to a new - generation chemotherapy, the PARP inhibitors, which is revolutionising drug treatments
in this
type of cancer.
And Dr Sara Erridge is running a clinical trial
in Edinburgh to find the best way to treat a
type of brain
tumour called glioma.
To help plug this diagnostic hole, Rebecca is leading the OCCAMS trial, a CRUK - funded multicentre study which is part of the International Cancer Genome Consortium (ICGC) global project to generate a comprehensive catalogue of genomic abnormalities
in 50
tumour types.
The team looked into whether NKG2D's roles
in chronic inflammation and cancer could help
tumours to grow
in these
types of cancer.
«It tells you about the ecosystem of the
tumour», Simona says, «using fluorescent markers, we can label many specific cell
types and structures within the brain
in the vicinity of the
tumour, and look not just at the
tumour cells but how they interact with their surroundings.
«We showed that there are markers on these stomach
tumour cells that indicate they would be responsive to a
type of immunotherapy called immune checkpoint inhibitors,
in particular anti-PDL1 immunotherapy, which is already used with great success
in the treatment of melanoma and certain other cancers.
We found 1,098 genes
in the sequence, of which 99 encode proteins expressed
in testis and
in various
tumour types.
«It's fascinating that it's so complicated», says Gerard, «there is a code we don't yet understand that differs from tissue to tissue — the number of chemokines and cytokines is distinct
in each tissue
type and the
types of cells that enter and exit the
tumour also differ».
Mutations
in p53, BRCA1 and chromosome instability are frequently associated with ovarian
tumour development, but little is know about the cytoskeleton organisation
in this
type of
tumours.
Inclusion Criteria: • Availability of tumor tissue for mesothelin expression testing • Histologically - confirmed, mesothelin - expressing metastatic or advanced non-metastatic disease (
tumour type specific inclusion criteria) • At least one measurable lesion according to either Response Evaluation Criteria
in Solid Tumors (RECIST) 1.1 or International Thymic Malignancy Interest Group (ITMIG) modified RECIST 1.1 as applicable • Adequate bone marrow, liver, renal and coagulation function • Left ventricular ejection fraction (LVEF) ≥ 50 % of the lower limit of normal (LLN) according to local institutional ranges • Eastern Cooperative Oncology Group (ECOG) 0 or 1 Exclusion Criteria: • More than one prior anti - tubulin / microtubule agent • Corneal epitheliopathy or any eye disorder that may predispose the patients to this condition • Symptomatic Central nervous system (CNS) metastases and / or carcinomatous meningitis • Contraindication to both CT and MRI contrast agents • Active hepatitis B or C infection • Pregnant or breast - feeding patients • Tumor
type specific exclusion criteria
(A) Demonstration of Slc6a14 mRNA up - regulation
in PyMT - driven mammary
tumours in mice; N, mammary tissue from wild -
type mice; T, mammary
tumour tissue from PyMT - Tg mice.
By comparing the conversations, the researchers made the surprising discovery that similar reactions were taking place
in different
tumour types.
Analysis of transcriptomes
in tumour tissues from wild -
type mice and Slc6a14 - null mice indicated no compensatory changes
in the expression of any other amino acid transporter mRNA.